TELA Bio
TELA
37 hedge funds and large institutions have $140M invested in TELA Bio in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 15 increasing their positions, 15 reducing their positions, and 9 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 15
0.15% less ownership
Funds ownership: 70.91% → 70.76% (-0.15%)
15% less capital invested
Capital invested by funds: $165M → $140M (-$24.9M)
18% less funds holding
Funds holding: 45 → 37 (-8)
89% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EWM
Essex Woodlands Management
The Woodlands,
Texas
|
+$3.54M |
| 2 |
AC
Armistice Capital
New York
|
+$1.17M |
| 3 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
+$386K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$163K |
| 5 |
JAMONY
Jacob Asset Management of New York
Hermosa Beach,
California
|
+$140K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
-$2.47M |
| 2 |
Millennium Management
New York
|
-$984K |
| 3 |
JG
Jefferies Group
New York
|
-$564K |
| 4 |
Two Sigma Investments
New York
|
-$396K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$349K |
TELA Hedge Fund Activity: Q3 2021 in Review
37 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in TELA Bio (TELA) for Q3 2021, worth a combined $140M — down 15% from $165M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of TELA and 1 opened new positions — a net loss of 8 holders — while 15 trimmed existing stakes and 15 added.
The largest buyer was Essex Woodlands Management, adding an estimated $3.54M. The largest seller was Pura Vida Investments, cutting an estimated $2.47M.
- 37 institutional investors held TELA Bio (TELA) as of Q3 2021, down from 45 in Q2 2021.
- Funds reported $140M of TELA Bio stock for Q3 2021, down 15% quarter-over-quarter.
- 1 fund opened new TELA Bio positions in Q3 2021 and 9 closed out, a net change of -8 holders.
- The largest TELA Bio buyer in Q3 2021 was Essex Woodlands Management, an estimated $3.54M added.
- The largest TELA Bio seller in Q3 2021 was Pura Vida Investments, an estimated $2.47M sold.
Based on aggregated 13F filings for Q3 2021.